EVH logo

Evolent Health, Inc. Stock Price

NYSE:EVH Community·US$505.0m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 15 Fair Values set on narratives written by author

EVH Share Price Performance

US$4.48
-6.02 (-57.33%)
US$5.75
Fair Value
US$4.48
-6.02 (-57.33%)
22.1% undervalued intrinsic discount
US$5.75
Fair Value
Price US$4.48
AnalystConsensusTarget US$5.75
AnalystLowTarget US$3.34
AnalystHighTarget US$8.00

EVH Community Narratives

·
Fair Value US$5.75 22.1% undervalued intrinsic discount

Value-based Care And Digital Automation Will Expand Future Opportunities

0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
·
Fair Value US$3.34 34.2% overvalued intrinsic discount

Digital Health Rivals And Regulatory Hurdles Will Erode Prospects

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value US$8 44.0% undervalued intrinsic discount

Aetna Partnership And Demographic Trends Will Redefine Care Delivery

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Trending Discussion

Updated Narratives

EVH logo

EVH: Rich P/E Assumptions Will Constrain Upside Despite Raised Price Objectives

Fair Value: US$3.34 34.2% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
EVH logo

EVH: Higher Margin Outlook And 2026 Earnings Guidance Will Support Future Upside

Fair Value: US$8 44.0% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
EVH logo

EVH: Conservative Reserves And New Contracts Will Support Future Earnings Recovery

Fair Value: US$5.75 22.1% undervalued intrinsic discount
9 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with mediocre balance sheet.

2 Risks
3 Rewards

Evolent Health, Inc. Key Details

US$1.9b

Revenue

US$1.5b

Cost of Revenue

US$381.2m

Gross Profit

US$915.0m

Other Expenses

-US$533.8m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-4.75
20.18%
-28.26%
245.6%
View Full Analysis

About EVH

Founded
2011
Employees
4200
CEO
Seth Blackley
WebsiteView website
www.evolent.com

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Recent EVH News & Updates

Narrative Update Jun 16

EVH: Rich P/E Assumptions Will Constrain Upside Despite Raised Price Objectives

Analysts have raised their price target on Evolent Health stock to $5.50 from $4.00, citing updated assessments of fair value, growth, margins, and future P/E assumptions. Analyst Commentary Recent research on Evolent Health frames the higher price targets within a mixed backdrop, where some analysts highlight potential upside while others emphasize execution and valuation risks.
Narrative Update Jun 01

EVH: Higher Margin Outlook And 2026 Earnings Guidance Will Support Future Upside

Analysts have lifted their price target on Evolent Health to $5.50 from $4.00, citing updated assumptions that include higher projected revenue growth, a wider profit margin, and a lower future P/E multiple in their models. Analyst Commentary Bullish analysts have recently highlighted Evolent Health as a stock where revised assumptions on revenue, margins, and valuation multiples support a higher potential share price.
Narrative Update May 18

EVH: Conservative Reserves And New Contracts Will Support Future Earnings Recovery

Analysts have lifted the consolidated price target on Evolent Health to $5.75 from $5.18, citing updated assumptions around revenue growth, profit margins and long term earnings power reflected in recent research moves from Citi, Canaccord and others. Analyst Commentary Recent research on Evolent Health shows a mix of optimism and caution as analysts recalibrate their expectations around earnings power, reserves and leverage.

Recent updates

No updates